Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis

Article English OPEN
Soares-Weiser, Karla ; Thomas, Sherine ; G, Gail Thomson ; Garner, Paul (2010)
  • Publisher: Springer Nature
  • Journal: BMC Infectious Diseases, volume 10, pages 207-207 (eissn: 1471-2334)
  • Related identifiers: doi: 10.1186/1471-2334-10-207, pmc: PMC2912908
  • Subject: wa_105 | Research Article | Infectious Diseases | wc_534 | qv_4

Background\ud Crimean-Congo Hemorrhagic Fever epidemics often occur in areas where health services are limited, and are associated with case fatality rates of 5-40%. Besides intensive care, ribavirin is often recommended. A solid evidence base for the use of this drug will help justify assuring access to the drug in areas where epidemics are common.\ud \ud Methods\ud We carried out a systematic review of observational and experimental studies of people with suspected or confirmed Crimean-Congo Haemorrhagic Fever that included comparisons between patients given ribavirin and those not. We extracted data on mortality, hospital stay, and adverse events. Risk of bias was assessed using a standard checklist, and data were presented in meta-analytical graphs, stratified by study design, and summary estimates were assessed using the GRADE method.\ud \ud Results\ud Twenty-one unique studies, including one randomised controlled trial of ribavirin, were included. Quality of the evidence was very low, with a Down and Black median score of 4 (maximum possible 33). Ribavirin treatment was not shown to be superior to no ribavirin treatment for mortality rate in a single RCT (RR: 1.13, 95%CI: 0.29 to 4.32, 136 participants, GRADE= low quality evidence); but ribavirin was associated with reduced mortality by 44% when compared to no ribavirin treatment in the pooled observational studies (RR: 0.56, 95%CI: 0.35 to 0.90, 955 participants; GRADE=very low quality evidence). Adverse events were more common with the ribavirin patients, but no severe adverse events were reported. No difference in length of hospital stay was reported.\ud \ud Conclusions\ud No clear message of benefit is available from the current data on ribavirin as observational data are heavily confounded, and the one trial carried out has limited power. However, ribavirin could potentially have large benefits in this condition and these results very clearly indicate a pragmatic, randomised controlled trial in the context of good quality supportive care is urgently needed and ethically justified.
  • References (55)
    55 references, page 1 of 6

    1. Burt FJ, Spencer DC, Leman PA, Patterson B, Swanepoel R: Investigation of tick-borne viruses as pathogens of humans in South Africa and evidence of Dugbe virus infection in a patient with prolonged thrombocytopenia. Epidemiol Infect 1996, 116:353-361.

    2. Clerx JP, Casals J, Bishop D: Structural Characteristics of Nairoviruses (Genus Nairovirus, Bunyaviridae). Journal of General Virology 1981, 55:165-178.

    3. Papa A MB, Kouidou S, Tang Q, Hang C, Antoniadis A: Genetic Characterization of the M RNA Segment of Crimean Congo Hemorrhagic Fever Virus Strains, China. Emerg Infect Dis 2002, 8:50-53.

    4. Papa A BB, Pavlidou V, Papadimitriou E, Pelemis M, Antoniadis A: Genetic detection and isolation of crimean-congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg Infect Dis 2002, 8:852-854.

    5. Causey OR, Kemp GE, Madbouly MH, David-West TS: Congo virus from domestic livestock, African hedgehogs, and arthropods in Nigeria. Am J Trop Med Hyg 1970, 19:846-850.

    6. Yu-Chen Y, Ling-Xiong K, Ling L, Yu-Qin Z, Feng L, Bao-Jian C, Shou-Yi G: Characteristics of Crimean-Congo hemorrhagic fever virus (Xinjiang strain) in China. Am J Trop Med Hyg 1985, 34:1179-1182.

    7. Saluzzo JF, Digoutte JP, Camicas JL, Chauvancy G: Crimean-Congo haemorrhagic fever and Rift valley fever in South-Eastern Mauritania. Lancet 1985, 1(8420):116.

    8. Shepherd AJ, Swanepoel R, Leman PA, Shepherd SP: Field and laboratory investigation of Crimean-Congo haemorrhagic fever virus (Nairovirus, family Bunyaviridae) infection in birds. Trans R Soc Trop Med Hyg 1987, 81:1004-1007.

    9. Hoogstraal H: The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 1979, 15:307-417.

    10. Swanepoel R, Shepherd AJ, Leman PA, Shepherd SP, McGillivray GM, Erasmus MJ, Searle LA, Gill DE: Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. Am J Trop Med Hyg 1987, 36:120-132.

  • Metrics
    No metrics available
Share - Bookmark